Have you ever heard of a condition where your immune system gets too overprotective and ends up causing more harm than good? That’s what happens in Antiphospholipid Antibody Syndrome (APS). It’s a ...

IGM Biosciences, Inc.’s IGMS share price has dipped by 6.85%, which has investors questioning if this is right time to buy.

The human immune system is highly complex and well-equipped to combat most bacteria. However, in some instances bacteria can cause life-threatening infections and the increase of antibiotic-resistant ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, announced that Randall ...

The levels of anti-COPT1-IgG and anti-COPT1-IgM autoantibodies were significantly higher in patients with NSCLC (P<0.05). Anti-COPT1-IgG and anti-COPT1-IgM could discriminate NSCLC from NC with area ...

Department of Nephrology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China ...

Inebilizumab significantly reduced the risk of treated and AC-determined IgG4-RD flare by 87% compared with placebo. The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab ...

Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 weeks in patients with primary immunoglobulin A nephropathy. The FDA ...

Unlike mammalian immunoglobulins, which are classified into five major types based on their function and structure, members of the IgSF in invertebrates exhibit a much broader diversity. Nevertheless, ...